Study guide
12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother
AMCB Certified Nurse-Midwife CNM
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care
1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral
2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts
2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy
3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy
3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy
4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss
4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care
5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance
5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion
6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation
6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy
7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair
7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture
8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation
8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications
9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage
9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation
10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health
10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis
11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination
11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes
12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days
12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days
13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization
13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening
14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation
14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral
15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders
15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome
16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause
16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis
17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions
17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking
18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity
18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care
12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother
Key Takeaways Explain This Topic AI
Routine glucose screening is not indicated for healthy asymptomatic term infants; it is reserved for infants of diabetic mothers, large- and small-for-gestational-age infants, late preterm infants, and those with perinatal stress.
Action thresholds are below 40 mg/dL from birth to 4 hours and below 45 mg/dL from 4 to 24 hours, with 40 percent dextrose gel 0.5 mL/kg buccally plus a feed as first-line treatment.
Newborns cannot shiver and generate heat through non-shivering thermogenesis in brown adipose tissue using uncoupling protein-1.
Cold stress raises oxygen and glucose consumption, producing hypoglycemia, metabolic acidosis, pulmonary vasoconstriction, and reduced surfactant production.
Skin-to-skin contact is the most effective warming intervention for a stable newborn, and the first bath should be delayed at least 24 hours.
Last updated: September 2026
Neonatal Hypoglycemia: Pathophysiology, Screening & Treatment
During gestation, maternal glucose crosses the placenta via facilitated diffusion, maintaining fetal blood glucose at roughly 70% to 80% of maternal concentrations. The fetus produces its own insulin. At delivery, the umbilical cord is clamped, abruptly terminating the maternal glucose supply while high circulating fetal insulin levels persist. Normal term neonates compensate by mobilizing hepatic glycogen stores via glycogenolysis and inducing gluconeogenesis, experiencing a physiological nadir in blood glucose at 1 to 2 hours of life before stabilizing.
High-Risk Target Populations for Hypoglycemia Screening
Routine blood glucose screening is NOT recommended for healthy, asymptomatic term infants . Screening is indicated exclusively for neonates with specific clinical risk factors:
Infants of Diabetic Mothers (IDM): Maternal hyperglycemia causes fetal hyperglycemia, inducing hypertrophy and hyperplasia of fetal pancreatic beta-cells. After delivery, excessive endogenous insulin secretion causes profound hyperinsulinemic hypoglycemia .
Large for Gestational Age (LGA): Birth weight >90th percentile (hyperinsulinism).
Small for Gestational Age (SGA) & Intrauterine Growth Restriction (IUGR): Birth weight <10th percentile. Compromised placental nutrient transport results in severely depleted hepatic glycogen stores, minimal adipose tissue, and impaired gluconeogenesis.
Late Preterm Infants (34 0/7 to 36 6/7 weeks): Immature hepatic enzyme systems, reduced glycogen reserves, and poor suck-swallow-breathe coordination.
Perinatal Stress & Sepsis: Perinatal asphyxia, hypothermia, meconium aspiration, maternal chorioamnionitis, or polycythemia (elevated metabolic consumption).
Clinical Thresholds & Screening Protocols (AAP Guidelines)
Timing: In at-risk infants, initiate feeding within 30 to 60 minutes of birth. Measure blood glucose 30 minutes after the first feeding , and before subsequent feedings every 2 to 3 hours for the first 12 to 24 hours.
Diagnostic Action Thresholds:
Birth to 4 hours of life: Target blood glucose is ≥40 mg/dL . Clinical action threshold: <40 mg/dL .
4 to 24 hours of life: Target blood glucose is ≥45 mg/dL . Clinical action threshold: <45 mg/dL .
Signs of Neonatal Hypoglycemia: Jitteriness, tremors, hypotonia (floppiness), lethargy, poor feeding, hypothermia, tachypnea, weak or high-pitched cry, cyanosis, apnea, and seizures. Stepwise Neonatal Hypoglycemia Management Cascade
- ├── Asymptomatic & Glucose <40 mg/dL (0-4h) or <45 mg/dL (4-24h)
- │ ├── Step 1: Administer Oral 40% Dextrose Gel 0.5 mL/kg into buccal mucosa + Feed immediately
- │ ├── Step 2: Recheck blood glucose in 30 to 60 minutes
- │ └── Step 3: If glucose remains below threshold after 2 doses of gel ──> Transfer for IV D10W
- └── Symptomatic Hypoglycemia (Any glucose <40 mg/dL with symptoms) OR Refractory Hypoglycemia
- ├── Step 1: Administer D10W (10% Dextrose) IV Bolus: 2 mL/kg (200 mg/kg) over 5-10 minutes
- └── Step 2: Initiate Continuous IV Dextrose Infusion: Glucose Infusion Rate (GIR) 6-8 mg/kg/min
First-Line Intervention — Oral 40% Dextrose Gel: For asymptomatic hypoglycemia, oral 40% dextrose gel ( 0.5 mL/kg ) massaged into the infant's buccal mucosa, combined with breast milk or formula feeding, is the evidence-based standard of care. Dextrose gel provides rapid transmucosal absorption, avoids separation of the maternal-infant dyad, and significantly reduces NICU admissions for IV therapy.
Intravenous Dextrose Resuscitation: Indicated for any infant with symptomatic hypoglycemia , or asymptomatic infants whose blood glucose remains persistently below threshold despite feeding and two doses of dextrose gel:
Administer an IV bolus of 10% Dextrose in Water (D10W) at 2 mL/kg (200 mg/kg) over 5 to 10 minutes.
Immediately initiate a continuous maintenance IV dextrose infusion at a Glucose Infusion Rate (GIR) of 6 to 8 mg/kg/min , calculated as: GIR (mg/kg/min) = Fluid Rate (mL/hr) × Dextrose Concentration (%) × 0.167 Weight (kg) \text{GIR (mg/kg/min)} = \frac{\text{Fluid Rate (mL/hr)} \times \text{Dextrose Concentration (\%)} \times 0.167}{\text{Weight (kg)}} GIR (mg/kg/min) = Weight (kg) Fluid Rate (mL/hr) × Dextrose Concentration (%) × 0.167
Precaution: Never administer concentrated dextrose (e.g., D25W or D50W) as an IV push; hypertonic solutions cause osmotic endothelial damage, intracranial hemorrhage, and trigger severe reactive rebound hyperinsulinemic hypoglycemia.
Neonatal Thermoregulation and Cold Stress
Supporting thermoregulation is a distinct blueprint task and the single intervention most often responsible for preventing the hypoglycemia just described.
Why Newborns Lose Heat So Fast
A large surface-area-to-mass ratio , thin skin, minimal subcutaneous fat, and a wet body surface at birth.
Newborns cannot shiver. They generate heat by non-shivering thermogenesis : norepinephrine triggers lipolysis in brown adipose tissue (interscapular region, nape of the neck, axillae, and around the kidneys and adrenals), where uncoupling protein-1 dissipates the proton gradient as heat instead of ATP.
The Four Routes of Heat Loss
- Mechanism Example at Birth Prevention
- Evaporation Wet amniotic fluid drying from the skin Dry immediately and remove wet linens
- Conduction Contact with a cold scale, mattress, or stethoscope Pre-warm all surfaces and instruments
- Convection Room drafts, air conditioning, open doors Delivery room at 23–25 °C, no drafts
- Radiation Proximity to a cold window or exterior wall Move the warmer or bassinet away from cold surfaces
- The Cold-Stress Cascade
Hypothermia is not merely uncomfortable — it sets off a self-reinforcing spiral:
Cold stress → increased oxygen and glucose consumption → hypoglycemia → anaerobic metabolism → metabolic acidosis → pulmonary vasoconstriction with worsening hypoxemia → reduced surfactant production → further cold stress.
Thresholds (axillary): normal 36.5–37.5 °C ; cold stress below 36.5 °C; moderate hypothermia below 36.0 °C.
Practical Prevention
Skin-to-skin contact with the mother is the most effective warming intervention for a stable newborn and outperforms a radiant warmer for thermal stability, glycemic stability, and breastfeeding success. Add a dry hat, cover both with a warmed blanket, and delay the first bath for at least 24 hours or until the temperature has been stable for several hours. For preterm infants below about 32 weeks, place the infant in a polyethylene wrap or bag without drying and use a warmed mattress.
The Infant of a Diabetic Mother
Infants of diabetic mothers concentrate several of these problems at once and should be assessed as a cluster: macrosomia with birth trauma risk , hyperinsulinemic hypoglycemia , hypocalcemia and hypomagnesemia , polycythemia (hematocrit above 65%) with subsequent hyperbilirubinemia , respiratory distress from insulin-impaired surfactant synthesis, and asymmetric septal hypertrophy . Infants of mothers with pregestational diabetes also carry an increased risk of structural anomalies — cardiac defects, neural tube defects, and caudal regression sequence — reflecting first-trimester hyperglycemia.